. . . . . . . . . . . . "a(SCHEM:Dinoprostone) -> r(HGNC:ST3GAL4)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Treatment with a COX-2 inhibitor, celecoxib... beta 3Gal-T5 and ST3Gal III and IV expression was inhibited by celecoxib and was enhanced by prostaglandin E(2) treatment." . . "Selventa" . . . . "2014-07-03T14:30:01.582+02:00"^^ . . .